Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae

Ian Morrissey; Glenn Tillotson

doi:10.1093/jac/dkh092

Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae

J Antimicrob Chemother. 2004 Feb;53(2):144-8. doi: 10.1093/jac/dkh092. Epub 2004 Jan 16.

Authors

Ian Morrissey¹, Glenn Tillotson

Affiliation

¹ GR Micro Ltd., 7-9 William Road, London NW1 3ER, UK. i.morrissey@grmicro.co.uk

PMID: 14729748
DOI: 10.1093/jac/dkh092

Abstract

This review focuses on the activity of gemifloxacin, a new respiratory fluoroquinolone, against the two most important bacterial pathogens associated with lower respiratory tract infections, namely Streptococcus pneumoniae and Haemophilus influenzae.

Publication types

Review

MeSH terms

Anti-Bacterial Agents / pharmacology*
Anti-Bacterial Agents / therapeutic use
Drug Resistance, Multiple
Fluoroquinolones / pharmacology*
Fluoroquinolones / therapeutic use
Gemifloxacin
Haemophilus Infections / drug therapy
Haemophilus Infections / microbiology
Haemophilus influenzae / drug effects*
Humans
Naphthyridines / pharmacology*
Naphthyridines / therapeutic use
Pneumococcal Infections / drug therapy
Pneumococcal Infections / microbiology
Streptococcus pneumoniae / drug effects*

Substances

Anti-Bacterial Agents
Fluoroquinolones
Naphthyridines
Gemifloxacin